Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
暂无分享,去创建一个
M. Masuda | Y. Kuratomi | R. Yasumatsu | N. Komune | S. Toh | T. Wakasaki | Takashi Nakagawa | Rina Jiromaru | K. Hashimoto | M. Matsuo | Tomomi Manako | M. Yamauchi | T. Takeuchi | Hirotaka Hara | Emi Nishimura | Takahiro Wakasaki